When Vas Narasimhan started as the new CEO of the Swiss drug giant Novartis, he began refocusing the company on a key business area: prescription medicines. Until recently, alongside top-selling ...

CNBC’s Angelica Peebles and Novartis CEO Vas Narasimhan join 'Squawk Box' to discuss the company's drug pipeline, managing patent cliffs, drug pricing under Trump, and more. TikTok was gone.

my family is ready to return to Silicon Valley and the US. I'm confident that Vas will be an excellent successor." Still only 41, Dr. Narasimhan is part of a new generation of leaders taking over ...

Narasimhan, a trained physician and former McKinsey consultant, has plotted his career to have the largest possible impact on public health. Now at Novartis, the giant Swiss pharmaceutical company ...

Novartis CEO Vas Narasimhan says the pharma industry hopes ... Nazis shattered her family’s store in 1938. She just learned it’s still there. I visited the city that's been nicknamed the ...

Novartis (NVS) CEO Vas Narasimhan told the Wall Street Journal the company is searching for next-generation obesity drug candidates, even if its main focus remains on therapeutic areas where it ...

Novartis CEO Vas Narasimhan outlined projections for the company's future at the 2025 JP Morgan Healthcare conference in San Francisco on 14 January. Novartis, he said, expects peak sales of over ...

In a conversation with 'Fast Company' Editor-in-Chief Stephanie Mehta, Novartis CEO Vas Narasimhan explained why the world failed to respond to the pandemic—and how we can eventually get back to ...